Stoke Therapeutics | 30.19 +0.29 +0.97% | ||
| STOK | |||
| 高 31.21 | 开 30.95 | 量 138.29万股 | 总市值 16.54亿 |
| 低 28.40 | 换 2.52% | 额 4121.92万 | 市盈TTM 31.52 |
分时
5日
日K
周K
月K
季K
年K
OYang
08-25 20:36
#药闻简讯# 2025年8月25日，$Biogen制药(BIIB)$ 与专注于通过RNA药物发挥人体潜能以恢复蛋白质表达的生物技术公司$Stoke Therapeutics(STOK)$ 今日宣布，将在第36届国际癫痫大会（IEC）上公布关于zorevunersen的最新临床研究数据。该大会将于2025年8月30日 至9月3日于葡萄牙里斯本举行的第36届国际...
6赞
Stoke Therapeutics(STOK)
09-03 04:45
$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-006649 Act: 33 Size: 8 KB 网页链接
Stoke Therapeutics(STOK)
09-04 05:55
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023590 Size: 8 KB 网页链接
Stoke Therapeutics(STOK)
09-04 05:55
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023591 Size: 5 KB 网页链接
Stoke Therapeutics(STOK)
09-04 05:55
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023589 Size: 16 KB 网页链接
Stoke Therapeutics(STOK)
09-19 04:15
$Stoke Therapeutics(STOK)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001193125-25-207401 Act: 34 Size: 140 KB 网页链接
Stoke Therapeutics(STOK)
08-27 05:45
$Stoke Therapeutics(STOK)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001123292-25-000387 Act: 34 Size: 34 KB 网页链接
Stoke Therapeutics(STOK)
08-19 08:25
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-022226 Size: 9 KB 网页链接
Stoke Therapeutics(STOK)
10-04 04:45
$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-007743 Act: 33 Size: 7 KB 网页链接
Stoke Therapeutics(STOK)
10-04 04:35
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001780088-25-000003 Size: 5 KB 网页链接
Stoke Therapeutics(STOK)
08-16 04:35
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-022074 Size: 5 KB 网页链接
Stoke Therapeutics(STOK)
08-07 00:25
$Stoke Therapeutics(STOK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-25-002118 Act: 34 Size: 11 KB 网页链接
Stoke Therapeutics(STOK)
08-13 04:05
$Stoke Therapeutics(STOK)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0000950170-25-107275 Act: 34 Size: 17 MB 网页链接
Stoke Therapeutics(STOK)
07-16 05:15
$Stoke Therapeutics(STOK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0002052113-25-002218 Act: 34 Size: 10 KB 网页链接
Stoke Therapeutics(STOK)
08-21 04:15
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-022441 Size: 5 KB 网页链接
Stoke Therapeutics(STOK)
08-30 04:25
$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-006558 Act: 33 Size: 6 KB 网页链接
Stoke Therapeutics(STOK)
10-06 19:35
$Stoke Therapeutics(STOK)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-25-230925 Act: 34 Size: 260 KB 网页链接
Stoke Therapeutics(STOK)
07-30 05:15
$Stoke Therapeutics(STOK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001085146-25-004276 Act: 34 Size: 6 KB 网页链接
Stoke Therapeutics(STOK)
08-15 04:35
$Stoke Therapeutics(STOK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-078641 Act: 34 Size: 13 KB 网页链接
Stoke Therapeutics(STOK)
08-19 08:25
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-022225 Size: 9 KB 网页链接